DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
de Lima Lopes Jr G, Segel JE, Tan DS.
et al Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung.
Cancer 2012;
118: 1032-1039
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.